Medical physics

RamSoft Acquires a Majority Stake in Meddiff to Advance Patient Care Globally

Retrieved on: 
Tuesday, July 6, 2021

RamSoft will continue to be headquartered in Toronto, Canada and the company's management team will be led by President and CEO Vijay Ramanathan.

Key Points: 
  • RamSoft will continue to be headquartered in Toronto, Canada and the company's management team will be led by President and CEO Vijay Ramanathan.
  • "Our commitment to saving patient lives through universal access to imaging is what drives us as a company.
  • To expand its global footprint and support this mission, RamSoftlooked towards Meddiff, a Bangalore-based company that has over 1,500 installed sites globally.
  • Built using cutting-edge, single database technology, our radiology, mammography, and enterprise imaging software enables practices tooptimize their workflow, cut costs, and overall, improve patient care.

RamSoft Acquires a Majority Stake in Meddiff to Advance Patient Care Globally

Retrieved on: 
Tuesday, July 6, 2021

RamSoft will continue to be headquartered in Toronto, Canada and the company's management team will be led by President and CEO Vijay Ramanathan.

Key Points: 
  • RamSoft will continue to be headquartered in Toronto, Canada and the company's management team will be led by President and CEO Vijay Ramanathan.
  • "Our commitment to saving patient lives through universal access to imaging is what drives us as a company.
  • To expand its global footprint and support this mission, RamSoftlooked towards Meddiff, a Bangalore-based company that has over 1,500 installed sites globally.
  • Built using cutting-edge, single database technology, our radiology, mammography, and enterprise imaging software enables practices tooptimize their workflow, cut costs, and overall, improve patient care.

Nanox to Present at the Ladenburg Thalmann Healthcare Conference

Retrieved on: 
Thursday, July 1, 2021

Mr. Poliakines presentation is scheduled for Wednesday, July 14, at 10:00am ET.

Key Points: 
  • Mr. Poliakines presentation is scheduled for Wednesday, July 14, at 10:00am ET.
  • Interested parties can also access the live audio webcast for this conference from the Investor Relations section of the Company's website at www.nanox.vision .
  • Nanox, founded by the serial entrepreneur Ran Poliakine, is an Israeli corporation that is developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications.
  • Nanox believes that its novel technology could significantly reduce the costs of medical imaging systems and plans to seek collaborations with world-leading healthcare organizations and companies to provide affordable, early detection imaging service for all.

Midstate Radiology Associates, LLC Announces Acquisition of Radiology Group, P.C.

Retrieved on: 
Wednesday, June 30, 2021

MERIDEN, Conn., BRANFORD, Conn., and HAMDEN, Conn., June 30, 2021 /PRNewswire-PRWeb/ -- Midstate Radiology Associates, LLC (MRA) announces the acquisition of Radiology Group, P.C.

Key Points: 
  • MERIDEN, Conn., BRANFORD, Conn., and HAMDEN, Conn., June 30, 2021 /PRNewswire-PRWeb/ -- Midstate Radiology Associates, LLC (MRA) announces the acquisition of Radiology Group, P.C.
  • This acquisition enables Midstate Radiology Associates, LLC to continue expanding their award winning imaging services to more convenient Connecticut locations.
  • In addition to providing the highest quality and affordable imaging services , Midstate Radiology Associates, LLC can now offer patients in the Hamden and Branford areas more enhanced comprehensive continuity of imaging care that is carefully coordinated with their doctor.
  • Midstate Radiology Associates, LLC, founded in 1955 in Central Connecticut, has grown into a leading and well-established medical imaging practice, providing medical imaging services throughout the state of Connecticut.

RadNet, Inc. and Jefferies to Host a Teach-In on Artificial Intelligence within Diagnostic Imaging

Retrieved on: 
Monday, June 28, 2021

RadNet, Inc. is the leading national provider of freestanding, fixed-site diagnostic imaging services and related information technology solutions (including artificial intelligence) in the United States based on the number of locations and annual imaging revenue.

Key Points: 
  • RadNet, Inc. is the leading national provider of freestanding, fixed-site diagnostic imaging services and related information technology solutions (including artificial intelligence) in the United States based on the number of locations and annual imaging revenue.
  • RadNet has a network of 346 owned and/or operated outpatient imaging centers.
  • RadNet's markets include California, Maryland, Delaware, New Jersey, New York, Florida and Arizona.
  • Together with affiliated radiologists, and inclusive of full-time and per diem employees and technicians, RadNet has a total of approximately 8,300 employees.

Center for Diagnostic Imaging Relaunches As RAYUS Radiology, Marking Major Step As It Accelerates Its National Growth Plan

Retrieved on: 
Monday, June 28, 2021

"Our transition to RAYUS Radiology and the 'SHINE ON' campaign highlights the brilliant people, practices, technology and services that already exist within our company.

Key Points: 
  • "Our transition to RAYUS Radiology and the 'SHINE ON' campaign highlights the brilliant people, practices, technology and services that already exist within our company.
  • As part of its national growth strategy, RAYUS Radiology is also completing acquisitions in key markets.
  • This month, RAYUS Radiology closed on the acquisition of InHealth Imaging in Washington, which has three locations in the Puget Sound market.
  • The RAYUS Radiology network is currently involved in more than 150 clinical trial protocols, offering advanced imaging options across every modality through its national network of diagnostic imaging centers and leading subspecialized radiologists.

Worldwide PET-CT Scanner Device Industry to 2028 - Featuring General Electric, Toshiba and Siemens Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, June 25, 2021

The global PET-CT scanner device market size is expected to reach USD 3.34 billion by 2028 according to a new study.

Key Points: 
  • The global PET-CT scanner device market size is expected to reach USD 3.34 billion by 2028 according to a new study.
  • The demand for digital device segment is expected to increase during the forecast period.
  • The use of digital scanner devices enhances the overall patient experience while improving accuracy, reducing scan time, and boosting the detectability of small lesions.
  • Leading market players such as GE, Philips, Siemens offer a wide range of mobile PET-CT scanner devices.

Global Contrast Media Market (2021 to 2028) - Share, Size, Trends and Industry Analysis Report - ResearchAndMarkets.com

Retrieved on: 
Friday, June 25, 2021

The "Contrast Media Market Share, Size, Trends, Industry Analysis Report, By Application; By Product; By Modality; By Regions; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Contrast Media Market Share, Size, Trends, Industry Analysis Report, By Application; By Product; By Modality; By Regions; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
  • The global contrast media market size is expected to reach USD 5.33 billion by 2028 according to a new study.
  • The report gives a detailed insight into current market dynamics and provides analysis on future market growth.
  • Contrast media are used to improve internal images produced by MRI, CT scans, X-rays and allows radiologists to the difference between normal and diseased tissues.

Vivos Inc Initiates Isopet® Therapy in Horses

Retrieved on: 
Thursday, June 24, 2021

Richland WA, June 24, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) Vivos Inc announced that it has completed the first IsoPet therapy on an equoid tumor.

Key Points: 
  • Richland WA, June 24, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) Vivos Inc announced that it has completed the first IsoPet therapy on an equoid tumor.
  • This is an exciting extension of Isopet, offering an important and unique treatment alternative for larger animals such as horses.
  • Dr. Mike Korenko stated, Expanding Isopet into the equine market is an important expansion of the Vivos business plan.
  • Vivos Inc. has developed an Yttrium-90 based injectable brachytherapy device, for the treatment of tumors in animals (IsoPet) and in humans (RadioGel).

Huntsman Cancer Institute Begins Treatment with Mevion Compact Proton Therapy System

Retrieved on: 
Thursday, June 24, 2021

Mevion Medical Systems today announced that the first proton center in the Mountain West, the Senator Orrin G. Hatch Center for Proton Therapy, has opened at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) and began treating patients on May 11th with the MEVION S250i Proton Therapy System.

Key Points: 
  • Mevion Medical Systems today announced that the first proton center in the Mountain West, the Senator Orrin G. Hatch Center for Proton Therapy, has opened at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) and began treating patients on May 11th with the MEVION S250i Proton Therapy System.
  • As the leading supplier of compact proton therapy systems in the United States, Mevion has been selected by more leading cancer centers, including NCI-Designated Cancer Centers, and has treated over 6,000 patients worldwide.
  • Since 2004, Mevion Medical Systems has been the leading provider of compact proton therapy systems for cancer care.
  • Mevions flagship product, the MEVION S250i Proton Therapy System with HYPERSCAN pencil beam scanning, is the worlds smallest proton therapy system that eliminates the obstacles of size, complexity, and cost that exists with other proton therapy systems.